| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/08/2007 | CA2603143A1 Improved botulinum toxin compositions |
| 02/07/2007 | EP1749891A1 Method and device for the in vitro detection of polycystic ovarian syndrome (pcos) and pathologies involving cardiovascular risk |
| 02/07/2007 | EP1749888A2 Soluble zalpha11 cytokine receptors |
| 02/07/2007 | EP1749886A2 Polypeptides having kinase activity, their preparation and use |
| 02/07/2007 | EP1749840A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 02/07/2007 | EP1749838A1 Interleukin-18-receptor proteins |
| 02/07/2007 | EP1749837A1 Methods and means for controlling the endocytosis and subsequent degradation of a cell surface protein |
| 02/07/2007 | EP1749836A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/07/2007 | EP1749833A1 Super-antigens derived from the SARS coronavirus E2 spike protein |
| 02/07/2007 | EP1749536A1 Activated factor X stimulants as new antihemorrhagic agents for topical use |
| 02/07/2007 | EP1749535A1 Remedy for diabetic neuropathy comprising gelatin gel as carrier |
| 02/07/2007 | EP1749530A2 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods [1998/31] |
| 02/07/2007 | EP1749524A2 Inflammation-inhibiting compounds |
| 02/07/2007 | EP1749028A1 Chimeric soluble hyper il-11 and use thereof |
| 02/07/2007 | EP1749022A2 Methods for cyclizing synthetic polymers |
| 02/07/2007 | EP1749018A1 Methods and kits for stabilising, protecting and solubilising proteins |
| 02/07/2007 | EP1748983A2 Compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 02/07/2007 | EP1748789A2 Biomarkers of resistance to hiv-infections in humans and biological applications thereof |
| 02/07/2007 | EP1748788A1 Hydrogel interferon formulations |
| 02/07/2007 | EP1748787A2 Method for fostering bone formation and preservation |
| 02/07/2007 | EP1748786A2 Dalbavancin compositions for treatment of bacterial infections |
| 02/07/2007 | EP1748785A1 Modulation of cartilage homeostasis |
| 02/07/2007 | EP1748784A2 Induction of innate immunity by vitamin d3 and its analogs |
| 02/07/2007 | EP1748783A2 Treatment or prevention of respiratory viral infections with immunomodulator compounds |
| 02/07/2007 | EP1748782A2 Methods and compositions for using alveolar macrophage phospholipase a2 |
| 02/07/2007 | EP1748781A1 Methods for treating bleeding disorders using sulfated polysaccharides |
| 02/07/2007 | EP1748776A1 Compositions for affecting weight loss |
| 02/07/2007 | EP1748760A1 Superloaded liposomes for drug delivery |
| 02/07/2007 | EP1457498B1 Novel peptide having angiotensin convertase inhibitory effect |
| 02/07/2007 | EP1315501B1 Alpha v integrin receptor antagonists |
| 02/07/2007 | EP1311675B1 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/07/2007 | EP1303186A4 Medicinal uses of mu-opioid receptor agonists |
| 02/07/2007 | EP1218491B1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 02/07/2007 | EP1092029B1 Human thrombopoietin mutein |
| 02/07/2007 | EP0833906B1 Novel ctla4/cd28 ligands and uses therefor |
| 02/07/2007 | EP0504363B2 PURIFIED IgG ANTIBODIES |
| 02/07/2007 | CN1910456A Marker for neuromyelitis optica |
| 02/07/2007 | CN1910294A Treatment strategies for immune-response disorders by using Fc receptor polymorphisms as diagnostics |
| 02/07/2007 | CN1910288A Integrase fusion proteins and their use with integrating gene therapy |
| 02/07/2007 | CN1910284A Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same |
| 02/07/2007 | CN1910283A Differentiation regulating agent containing gene which regulating differentiation from stem cells into natural killer cells as effective ingredient |
| 02/07/2007 | CN1910201A Glucagon-like peptide-1 analogs with long duration of action |
| 02/07/2007 | CN1910200A Homogeneous preparations of IL-28 and IL-29 |
| 02/07/2007 | CN1910199A Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use |
| 02/07/2007 | CN1909930A Transglutaminase mediated conjugation of peptides |
| 02/07/2007 | CN1909926A The use of cytokine able to bind IL-18BP and of inhibiting the activity of a second cytokine |
| 02/07/2007 | CN1909921A Compositions for reducing bacterial carriage and cns invasion and methods of using same |
| 02/07/2007 | CN1909920A Method for the delivery of sustained release agents |
| 02/07/2007 | CN1909919A Composition for the treatment of digestive pathologies |
| 02/07/2007 | CN1909918A T cell immunoreaction inhibitor |
| 02/07/2007 | CN1909917A Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension |
| 02/07/2007 | CN1908170A Lim mineralization protein splice variants |
| 02/07/2007 | CN1908016A Fusion protein with protein transduction structure field TAT-PTD and application thereof |
| 02/07/2007 | CN1908014A Modified peptides as therapeutic agents |
| 02/07/2007 | CN1908010A Furin enzyme inhibitor of resisting HIV-1 and preparation method thereof |
| 02/07/2007 | CN1908009A Acetes chinensis protein antigypertensive peptide and preparation method and application thereof |
| 02/07/2007 | CN1908008A Acetes chinensis protein antigypertensive peptide and preparation method and application thereof |
| 02/07/2007 | CN1907495A Application of Resistin binding polypeptide for preparing medicine promoting insulin secretion |
| 02/07/2007 | CN1907492A Application of GTP enzyme in antineoplastic preparing process |
| 02/07/2007 | CN1907491A Application of hepatocyte growth promoting factors in medicine for treating diffuse interstitial pneumonia |
| 02/07/2007 | CN1907490A Application of NYGGF4 gene sequence for preparing medicine affecting lipocyte proliferation |
| 02/07/2007 | CN1907262A Technology for preparing liquid drugs injection of liver cell growth promoting factor |
| 02/07/2007 | CN1298862C Glycoprotein and process for producing same |
| 02/07/2007 | CN1298851C Polypeptide |
| 02/07/2007 | CN1298844C MSH5 ablated mice and use therefor |
| 02/07/2007 | CN1298743C Fusion protein, gene encoding same, and use thereof |
| 02/07/2007 | CN1298739C Anti-bacterial agent |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/07/2007 | CN1298386C Prepn process of slow release parathyroid hormone microballoon |
| 02/07/2007 | CN1298385C Vaccin of heterogenous blood vessel endothetial cell growth factor and preparing process thereof |
| 02/07/2007 | CN1298312C Process for preparing particle, particle and its pharmic composition |
| 02/06/2007 | USRE39485 Administering glutamine or a glutamine analogue orally and topically to the mouth, of the patient in addition to the chemotherapy and/or radiotherapy so that stomatitis or esophagitis is alleviated |
| 02/06/2007 | US7173122 Antisense oligonucleotides to type I procollagen |
| 02/06/2007 | US7173118 Nogo receptor homologs |
| 02/06/2007 | US7173117 Codon optimised recombinant Dermaphagoides allergens |
| 02/06/2007 | US7173116 Nucleic acid formulations for gene delivery and methods of use |
| 02/06/2007 | US7173115 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer |
| 02/06/2007 | US7173113 Endothelial growth factor-follicle stimulating hormone compounds having increased serum half-lives relative to native hormones; for increasing fertility, egg production and spermatogenesis, and increasing vascularization in tissue |
| 02/06/2007 | US7173110 Peptide anti-tumor agent |
| 02/06/2007 | US7173109 Peptide sequence derived from the ghrelin polypeptide, coupled to a cystine amino acid, labeled with a fluorescent dye; used in high throughput screening to identify and characterize cellular receptors |
| 02/06/2007 | US7173108 Comprises tyrosine phosphatase peptides for diagnosis, prevention and treatment of autoimmune diseases; immunotherapy |
| 02/06/2007 | US7173107 Glycopeptide and preparation thereof |
| 02/06/2007 | US7173057 Compounds as enzyme inhibitors to treat hepatitis with viricides |
| 02/06/2007 | US7173020 Anticancer agents and drug delivery agents with nucleotides |
| 02/06/2007 | US7173018 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; headaches |
| 02/06/2007 | US7173014 For therapy of HIV infection |
| 02/06/2007 | US7173013 Administering a peptide compound |
| 02/06/2007 | US7173012 Hypoglycaemic peptides and methods of use thereof |
| 02/06/2007 | US7173011 Radiation therapy methods |
| 02/06/2007 | US7173010 Orphanin FQ receptor |
| 02/06/2007 | US7173009 Surfactant protein C esters |
| 02/06/2007 | US7173008 Lyophilized HGF preparations |
| 02/06/2007 | US7173007 Topical administration of cathelin-like cationic antimicrobial peptides |
| 02/06/2007 | US7173006 Drug comprising synthetic peptide analogs for the treatment of cancer |
| 02/06/2007 | US7173005 Insulin and IGF-1 receptor agonists and antagonists |
| 02/06/2007 | US7173004 Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus |
| 02/06/2007 | US7173003 Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| 02/06/2007 | US7173001 Method for regulating neuron development and maintenance |
| 02/06/2007 | US7173000 Modified factor VIIa |
| 02/06/2007 | US7172999 Using carbohydrates or zwitterions |